title: [The role of sphingomyelin cycle and tumor necrosis factor alpha in toxic effect of beta-amyloid peptide].
authors.forename: A V
authors.initials: AV
authors.lastname: Alesenko
authors.forename: A E
authors.initials: AE
authors.lastname: Bugrova
authors.forename: L N
authors.initials: LN
authors.lastname: Dudnik
authors.forename: V G
authors.initials: VG
authors.lastname: Korobko
authors.forename: L N
authors.initials: LN
authors.lastname: Shingarova
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000009:adverse effects*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002518:Ceramides / Q000096:biosynthesis; D002531:Cerebellum / Q000187:drug effects / Q000201:enzymology; D002855:Chromatography, Thin Layer / Q000295:instrumentation; D004195:Disease Models, Animal; D006624:Hippocampus / Q000187:drug effects / Q000201:enzymology; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D016229:Amyloid beta-Peptides; D002518:Ceramides; D014409:Tumor Necrosis Factor-alpha; D013108:Sphingomyelin Phosphodiesterase